Matches in SemOpenAlex for { <https://semopenalex.org/work/W138342144> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W138342144 endingPage "6" @default.
- W138342144 startingPage "952" @default.
- W138342144 abstract "Controlled studies in humans have shown the role of antibodies to tumor necrosis factor-alpha in the treatment of both fistulizing and inflammatory Crohn's disease. The aim of this study is to report the results of a multicenter clinical trial to evaluate efficacy of infliximab in Crohn's disease patients who are refractory to conservative drugs or fistulizing Crohn's disease.This trial was carried out at 5 university and community hospitals, in Turkey. A total of 25 patients with Crohn's disease that were unresponsive to conventional medical therapy, participated; 17 of the 25 were in the fistulizing disease group and 8 were in the inflammatory disease group. Clinical response was classified according to fistula drainage, diarrhea as positive response or no response.Overall response rate was 92% (23/25), regardless of the disease group, after first infusion of infliximab. Sixteen out of 17 patients in the fistulizing disease group had a positive response. Fourteen of the 16 positive responders later relapsed. Median duration of response was 8 weeks (range, 2-35 wk). Active inflammatory disease patients had a positive response rate of 75% (6/8) and two of the patients were nonresponders. A further two patients relapsed at week 14. Two patients in both arms of the study were still in remission at the end of the study. Major adverse events were: pneumonia in one patient, skin infections in two patients, pulmonary thromboembolism and death in one patient.Infliximab treatment seems to be more effective in Crohn's disease patients especially in those with fistulizing disease than those with non-fistulizing, inflammatory disease. It is evident that maintenance of remission might be achieved with ongoing maintenance therapy. We suggest maintenance of infliximab therapy." @default.
- W138342144 created "2016-06-24" @default.
- W138342144 creator A5000468433 @default.
- W138342144 creator A5005523046 @default.
- W138342144 creator A5011114835 @default.
- W138342144 creator A5011538557 @default.
- W138342144 creator A5021448014 @default.
- W138342144 creator A5039050011 @default.
- W138342144 creator A5042101236 @default.
- W138342144 creator A5055268054 @default.
- W138342144 creator A5069937418 @default.
- W138342144 creator A5071234313 @default.
- W138342144 creator A5086754252 @default.
- W138342144 creator A5091912115 @default.
- W138342144 date "2003-07-09" @default.
- W138342144 modified "2023-10-03" @default.
- W138342144 title "Clinical outcome of Crohn's disease treated with infliximab." @default.
- W138342144 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12845957" @default.
- W138342144 hasPublicationYear "2003" @default.
- W138342144 type Work @default.
- W138342144 sameAs 138342144 @default.
- W138342144 citedByCount "1" @default.
- W138342144 crossrefType "journal-article" @default.
- W138342144 hasAuthorship W138342144A5000468433 @default.
- W138342144 hasAuthorship W138342144A5005523046 @default.
- W138342144 hasAuthorship W138342144A5011114835 @default.
- W138342144 hasAuthorship W138342144A5011538557 @default.
- W138342144 hasAuthorship W138342144A5021448014 @default.
- W138342144 hasAuthorship W138342144A5039050011 @default.
- W138342144 hasAuthorship W138342144A5042101236 @default.
- W138342144 hasAuthorship W138342144A5055268054 @default.
- W138342144 hasAuthorship W138342144A5069937418 @default.
- W138342144 hasAuthorship W138342144A5071234313 @default.
- W138342144 hasAuthorship W138342144A5086754252 @default.
- W138342144 hasAuthorship W138342144A5091912115 @default.
- W138342144 hasConcept C126322002 @default.
- W138342144 hasConcept C141071460 @default.
- W138342144 hasConcept C197934379 @default.
- W138342144 hasConcept C2777138892 @default.
- W138342144 hasConcept C2777914695 @default.
- W138342144 hasConcept C2778260677 @default.
- W138342144 hasConcept C2779134260 @default.
- W138342144 hasConcept C2779280984 @default.
- W138342144 hasConcept C71924100 @default.
- W138342144 hasConcept C90924648 @default.
- W138342144 hasConceptScore W138342144C126322002 @default.
- W138342144 hasConceptScore W138342144C141071460 @default.
- W138342144 hasConceptScore W138342144C197934379 @default.
- W138342144 hasConceptScore W138342144C2777138892 @default.
- W138342144 hasConceptScore W138342144C2777914695 @default.
- W138342144 hasConceptScore W138342144C2778260677 @default.
- W138342144 hasConceptScore W138342144C2779134260 @default.
- W138342144 hasConceptScore W138342144C2779280984 @default.
- W138342144 hasConceptScore W138342144C71924100 @default.
- W138342144 hasConceptScore W138342144C90924648 @default.
- W138342144 hasIssue "52" @default.
- W138342144 hasLocation W1383421441 @default.
- W138342144 hasOpenAccess W138342144 @default.
- W138342144 hasPrimaryLocation W1383421441 @default.
- W138342144 hasRelatedWork W1601586932 @default.
- W138342144 hasRelatedWork W1990347817 @default.
- W138342144 hasRelatedWork W2047158379 @default.
- W138342144 hasRelatedWork W2094587323 @default.
- W138342144 hasRelatedWork W2124925219 @default.
- W138342144 hasRelatedWork W2339123909 @default.
- W138342144 hasRelatedWork W2401059760 @default.
- W138342144 hasRelatedWork W2952464799 @default.
- W138342144 hasRelatedWork W2151737448 @default.
- W138342144 hasRelatedWork W3139565444 @default.
- W138342144 hasVolume "50" @default.
- W138342144 isParatext "false" @default.
- W138342144 isRetracted "false" @default.
- W138342144 magId "138342144" @default.
- W138342144 workType "article" @default.